SS&C Technologies Other Income (Expense) increased by 119.8% to $6.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.6%, from $7.20M to $6.80M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 8.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.50M | -$44.90M | $38.60M | -$9.00M | -$20.40M | $1.10M | $49.10M | $5.40M | $14.90M | -$5.00M | $5.40M | $6.60M | $600.00K | $9.30M | $7.20M | -$1.10M | $5.30M | -$34.40M | $6.80M |
| QoQ Change | — | -790.8% | +186.0% | -123.3% | -126.7% | +105.4% | >999% | -89.0% | +175.9% | -133.6% | +208.0% | +22.2% | -90.9% | >999% | -22.6% | -115.3% | +581.8% | -749.1% | +119.8% |
| YoY Change | — | — | — | — | -413.8% | +102.4% | +27.2% | +160.0% | +173.0% | -554.5% | -89.0% | +22.2% | -96.0% | +286.0% | +9.1% | -283.3% | -43.0% | — | -5.6% |